No retraction, correction or concern found when last checked on Oct 22, 2026.
Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells
Huafang Su, Fuqiang Lin, Xia Deng and 9 more
Journal of Translational Medicine · 2016
Abstract
Background. Acquired radioresistance during radiotherapy is considered as the most important reason for local tumor recurrence or treatment failure. Circular RNAs (circRNAs) have recently been identified as microRNA sponges and involve in various biological processes. The purpose of this study is to investigate the role of circRNAs in the radioresistance of esophageal cancer.
Methods. Total RNA was isolated from human parental cell line KYSE-150 and self-established radioresistant esophageal cancer cell line KYSE-150R, and hybridized to Arraystar Human circRNA Array. Quantitative real-time PCR was used to confirm the circRNA expression profiles obtained from the microarray data. Bioinformatic tools including gene ontology (GO) analysis, KEGG pathway analysis and network analysis were done for further assessment.
Results. Among the detected candidate 3752 circRNA genes, significant upregulation of 57 circRNAs and downregulation of 17 circRNAs in human radioresistant esophageal cancer cell line KYSE-150R were observed compared with the parental cell line KYSE-150 (fold change ≥2.0 and P < 0.05). There were 9 out of these candidate circRNAs were validated by real-time PCR. GO analysis revealed that numerous target genes, including most microRNAs were involved in the biological processes. There were more than 400 target genes enrichment on Wnt signaling pathway. CircRNA_001059 and circRNA_000167 were the two largest nodes in circRNA/microRNA co-expression network.
Conclusions. Our study revealed a comprehensive expression and functional profile of differentially expressed circRNAs in radioresistant esophageal cancer cells, indicating possible involvement of these dysregulated circRNAs in the development of radiation resistance.
Electronic supplementary material. The online version of this article (doi:10.1186/s12967-016-0977-7) contains supplementary material, which is available to authorized users.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.
Background
Esophageal cancer is the eighth most frequently diagnosed and the sixth highest mortality rate cancer in the world. The 5-year survival rate of esophageal cancer patients with localized disease is less than 20 %. Radiation therapy (RT) plays a crucial role in the treatment of esophageal cancer. Although complex multidisciplinary methods incorporating surgery, chemotherapy, and radiotherapy had been applied in the treatment of esophageal cancer, the rate of local recurrence and distant metastasis remains high. Radiotherapy resistance has been considered as one of the most important reasons for local tumor recurrence or treatment failure.
Circular RNAs (circRNAs), unlike the well known linear RNA, forms a covalently closed continuous loop. CircRNAs are integral, conserved, and demonstrated to be resistant to RNase R treatment. With the advent of novel biochemical and computational approaches, circRNAs have been represented as a research hotspot in the RNA field. Accumulating evidence demonstrated that circRNAs involve in the development of several types of diseases, such as Alzheimer’s disease, atherosclerotic vascular disease and cancer. Recent studies found that circRNAs can function as microRNAs (miRNAs) sponges, RNA-binding protein sequestering agents, and nuclear transcriptional regulators. The recently identified circRNA, ciRS-7, which acts as a designated miR-7 sponge, involves in competing in endogenous RNA networks.
We previously developed a radioresistant esophageal squamous cancer cell line (KYSE-150R) by irradiating esophageal cancer cells KYSE-150 with gradient dose. To explore the underlying molecular regulation mechansim of circRNAs in the radioresistance, circular RNA microarray was used to detect the differential expressed circRNAs between radioresistant esophageal cell line KYSE-150R and the parental cell line KYSE-150. Our results suggested that the aberrant expression of circRNAs may play a role in transformation of radiation resistance of esophageal cancer cells.
Cell culture and reagents
Human esophageal squamous cancer cell lines KYSE-150 were purchased from the American Type Culture Collection (Manassas, VA, USA). Radioresistant cell line KYSE-150R has been previously established in our department by gradient dose irradiation treatment. Both KYSE-150 and KYSE-150R were cultured in RPMI-1640 (Gibco, Life Technologies Inc., Grand Island, NY, USA) with 100 unit/ml of penicillin, 100 mg/ml of streptomycin, and 10 % fetal bovine serum at 37 °C in a humidified incubator containing 5 % CO2. The cell lines were sub-cultured every 2–3 days following digestion at room temperature with 0.5 ml trypsin/EDTA per well (Sigma-Aldrich Ltd, UK).The viability was reported as the percentage of the viable cells number to the total cells number. There was an average viability over 95 %, determined by Trypan Blue staining.
RNA isolation, purification and hybridization
Three samples were collected from each of the two cell cultural groups and used for the following RNA extraction. Total RNA from each sample was treated with Rnase R (Epicentre, Inc.) to remove linear RNAs and to enrich circRNAs. Then, the enriched circRNAs were amplified and transcribed into fluorescent cRNA utilizing a random priming method (Arraystar Super RNA Labeling Kit; Arraystar). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen). The concentration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA) were measured by NanoDrop ND-1000. One μL of each labeled cRNA was fragmented by adding 5μL 10× Blocking Agent and 1 μL of 25× Fragmentation Buffer, and then the mixture was heated at 60 °C for 30 min. Finally 25 μL 2× Hybridization buffer was added to dilute the labeled cRNA. Hybridization solution of 50 μL was dispensed into the gasket slide and assembled to the circRNA expression microarray slide. The slides were incubated for 17 h at 65 °C in an Agilent Hybridization Oven. The hybridized arrays were washed, fixed and scanned using the Agilent Scanner G2505C.
Microarray data analysis
Scanned images were imported into Agilent Feature Extraction software (version 11.0.1.1) for raw data extraction. Quantile normalization of raw data and subsequent data processing were performed using the R software package. After quantile normalization of the raw data, low intensity filtering was performed. The circRNAs with at least 3 out of 6 samples flagged in “P” or “M” (“all targets value”) were retained for further analysis. When comparing the profile differences between two groups (such as disease versus control), the “fold change” (i.e. the ratio of the group averages) between the groups for each circRNA was computed. The statistical significance of the difference may be conveniently estimated by t test. CircRNAs having fold changes ≥2 and P values <0.05 were selected as of significantly differential expression.
Real-time PCR validation
Quantitative Real-time PCR was used to confirm the circRNA expression profiles obtained from the microarray data. Total RNA was extracted from cells using Trizol Reagent (Invitrogen) and reversely transcribed into cDNA using Super Script TM III Reverse Transcriptase (Invitrogen) according to a standard protocol. The relative gene expression was determined using ViiA 7 Real-time PCR System (Applied Biosystems). All samples were normalized to the signal generated from GAPDH (Sangon Biotech, Shanghai, China). Data was shown as fold change (2−ΔΔCt) and analyzed initially using Opticon Monitor Analysis Software V2.02 (MJ Research, Waltham, MA, USA). Triplicates were performed for each sample in three independent experiments. Primer sequences were presented in Additional file 1: Table S1.
MicroRNA prediction
The circRNA/microRNA interaction was predicted with Arraystar’s home-made miRNA target prediction software (Rockville, USA), whose principles are based on the TargetScan and miRanda prediction algorithm. The differentially expressed circRNAs within all the comparisons were annotated in detail with the circRNA/miRNA interaction information.
MicroRNA target genes prediction and GO analysis
To further investigate the functional roles of microRNA, putative targets of miRNAs were predicted by TargetScan software. GO analysis was performed to explore the functional roles of target genes in terms of biological processes, cellular components and molecular functions. Biological pathways defined by Kyoto Encyclopedia of Genes and Genomes (KEGG), Biocarta and Reactome (http://www.genome.jp/kegg/) were identified by Database for Annotation, Visualization and Integrated Discovery (DAVID; http://www.david.abcc.ncifcrf.gov/).
CircRNA-microRNA co-expression network
To further elucidate correlations between circRNAs and microRNA, potential microRNA-circRNA-mRNA interaction analysis was conducted by Cytoscape. The size of each node represents the number of putative microRNA functionally connected to each circRNA.
Statistical analysis
The results were reported as mean ± SD for triplicate measurements. Statistically significant differences between groups were estimated by the Student’s t test using SPSS (13.0). P < 0.05 was considered as being statistically significant.
Overview of circRNAs profiles
The expression of 3752 human circRNAs was quantitated for esophageal cancer KYSE-150R and KYSE-150 cell samples using microarray platform (Additional file 2: Table S2). Hierarchical clustering and scatter plot visualization showed that the circRNAs expression levels were distinguishable and variations (Fig. 1). The expression profiles of 74 circRNAs were differentially expressed (fold change ≥2.0 and P < 0.05) between the KYSE-150R and KYSE-150 cells, in which 57 circRNAs were found to be upregulated and 17 circRNAs were downregulated more than two-fold in KYSE-150R cells (Tables 1, 2). Among these, The expression levels of circRNA_100385, circRNA_104983 and circRNA_001059 were upregulated in KYSE-150R by 41.06, 11.68 and 6.16-folds, respectively. Meanwhile, circRNA_101877, circRNA_102913, and circRNA_000695 were downregulated by 3.53, 2.69 and 2.51-folds, respectively.
Real-time quantitative PCR validation
To validate the microarray profiling expression data, real-time quantitative RT-PCR revealed 4 upregulated and 5 downregulated expressed circRNAs as shown in Fig. 2. Expression levels detected by the two methods were consistent with each other, demonstrating the high reliability of the microarray expression results.
MicroRNA prediction and bioinformatics analyses
MicroRNA prediction was done with Arraystar’s home-made miRNA target prediction software based on miRanda (Table 3; Additional file 3: Table S3, Additional file 4: Table S4). There were 12 out of 17 downregulated circRNAs had target microRNAs. The results of Gene Ontology enrichment analysis on the up and down regulated circRNAs with identified target genes were shown in Fig. 3 and Additional file 5: Table S5. Gene Ontology analysis revealed that numerous target genes were involved in the biological processes, such as cellular process, regulation of biological process, metabolic process, etc. These processes were associated with human tumorigenesis and metastasis. KEGG analysis showed that there were 10 pathways related to upregulated circRNAs, including Olfactory transduction, Spliceosome, Glutamatergic synapse, and Phosphatidylinositol signaling system, and 17 pathways related to downregulated circRNAs, including Neurotrophin signaling pathway, Wnt signaling pathway, Microbial metabolism in diverse environments and Insulin signaling pathway (Fig. 4; Additional file 6: Table S6). Especially, there were more than 400 target genes enrichment in Wnt signaling pathway.
CircRNA-microRNA co-expression network
Potential connections between circRNA and microRNA were explored by using Cytoscape. As shown in Fig. 5, CircRNA_001059 and circRNA_000167 were the two largest nodes in the network.
Discussion
Acquired radioresistance has been considered as one of the most important reasons causing treatment failure for esophageal cancer patients. In this study, we explored the expression patterns of circRNAs between radioresistant esophageal cancer cell line KYSE-150R and its parental cell line KYSE-150 with Arraystar Circular RNA Microarray to investigate the mechanisms of acquired radioresistance of esophageal cancer. Differentially expressed profiles of circRNAs in radioresistant esophageal cancer cells were observed and validated compared with the parental esophageal cancer cells, indicating possible involvement of these dysregulated circRNAs in the development of radiation resistance of esophageal cancer cells.
CircRNAs are discovered as new special kind of ubiquitous endogenous noncoding RNAs. Recent evidences revealed that circRNAs can function as miRNA sponges and regulate parent gene expression to affect disease. Despite the potential importance of circRNAs reported in several types of cancer, there is no reported studies on the functional roles of circRNAs in the radiation resistance of cancer. In this study, there were 57 circRNAs significantly upregulated and 17 circRNAs significantly downregulated in the KYSE-150R cell lines compared with KYSE-150, respectively. In which, circRNA_100385, circRNA_104983 and circRNA_001059 were upregulated with top magnitudes. CircRNA_101877, circRNA_102913, and circRNA_000695 were downregulated with top magnitudes. The expression pattern of these circRNAs were validated by qRT-PCR, and consistent results were observed. Our results indicated that the altered expression levels of circRNAs may be related to their involvement in the transcription level regulation on the radiation resistance of esophageal cancer cells. Aberrant expression of circRNAs has been linked to carcinogenesis and the malignant behavior of many different cancer. The abundance of a circRNA called hsa_circ_002059 has been reported to be significantly downregulated and suggested as a potential diagnostic marker for gastric cancer. Qin M et al. found that hsa_circ_0001649 may play a role in tumorigenesis and metastasis of hepatocellular carcinoma. Li et al. reported that cir-ITCH might influence the expression level of ITCH and may be involved in the development of esophageal squamous cell carcinoma. However, no obvious changes of cir-ITCH was observed in this study, suggesting it may have no contribution to the radioresistance of esophageal cancer cells.
Despite the lack of knowledge of the exact functions of most circRNAs, we investigated the potential targets of these altered miRNAs. In a total, 57 upregulated circRNAs were identified to regulate the expression level of 120 microRNAs using the miRanda software, and 12 downregulated circRNAs were identified to regulate 36 microRNAs. According to the findings of Denzler et al. low levels of circRNAs may not be sufficient to affect the target miRNAs. The circRNA-microRNA co-expression network analysis were conducted for our Top-5 circRNAs in this study. Two potential crucial circRNAs, circRNA_001059 and circRNA_000167 were identified to be influential on target miRNAs. CircRNAs were believed to negatively regulate miRNAs, and contribute substantially to the competing endogenous RNA (ceRNA) network. It has been reported that ciRS-7, as a circular miR-7 inhibitor, harbors more than 60 conventional miR-7 binding sites, which is far more than any known linear sponges. Sex-determining region Y (SRY) was another identified miRNA sponge and functioned as a miR-138 sponge. According to our results, we hypothesized that circRNA_001059 may act as an inhibitor of miRNA by binding several specific miRNAs, including miR-30c-1*, miR-30c-2*, miR-122*, miR-139-3p, miR-339-5p and miR-1912. Our results implied that it is worthwhile to further investigate these novel dysregulated circRNAs as microRNA sponges and their potential biological functions in the development of radiation resistance.
In this study, GO analysis and KEGG pathway annotation were conducted to investigate the functions of related microRNAs. GO enrichment analysis revealed that target genes were involved in the regulation of crucial biological processes, indicating that regulating these genes in the cellular response is of great importance during the development of radioresistance. Among the upregulated pathways found in this study, phosphatidylinositol signaling pathway had been reported to be a key mediator of tumor cell responsiveness to radiation. Phosphatidylinositol 3-kinase (PI3K)/Akt pathway accelerates the repair of DNA-DSB (DNA double-strand breaks), and consequently, its activation leads to therapy resistance. Wnt signaling pathway which corresponds to downregulated circRNAs had also been reported to play predominant roles in radioresistance in Glioblastoma and prostate cancer. These results were also in line with the observations reported in our previous study.
Conclusions
In a conclusion, a unique set of circRNAs and their expression profiles were found in radioresistant esophageal cancer cells. Furthermore, their potential roles were investigated by bioinformatics analysis. Pathway analysis suggested that Wnt signaling pathway may be involved in the radioresistance. Network analysis uncovered two potential key circRNAs, i.e. circRNA_001059 and circRNA_000167. Our results would be helpful for future studies on investigating the molecular functions of circRNAs in radiotherapy resistance.
References 35
- 1.
Conteduca V, Sansonno D, Ingravallo G, Marangi S, Russi S, Lauletta G, Dammacco F. Barrett’s esophagus and esophageal cancer: an overview. Int J Oncol. 2012;41(2):414-424.
Not in our library10.3892/ijo.2012.1481
- 2.
Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34):5598-5606.
Not in our library10.3748/wjg.v19.i34.5598
- 3.
Cellini F, Valentini V. Targeted therapies in combination with radiotherapy in oesophageal and gastroesophageal carcinoma. Curr Med Chem. 2014;21(8):990-1004.
Not in our library10.2174/09298673113209990236
- 4.
Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, Gebski V. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681-692.
Not in our library10.1016/s1470-2045(11)70142-5
- 5.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074-2084.
Not in our library10.1056/nejmoa1112088
- 6.
Ding M, Zhang E, He R, Wang X. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy. Cancer Sci. 2013;104(11):1401-1410.
Not in our library10.1111/cas.12252
- 7.
Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141-148.
Not in our library10.1016/j.canlet.2015.06.003
- 8.
Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, Goodall GJ. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125-1134.
Not in our library10.1016/j.cell.2015.02.014
- 9.
- 10.
Rybak-Wolf A, Stottmeister C, Glažar P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, Herzog M, Schreyer L, Papavasileiou P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870-885.
Not in our library10.1016/j.molcel.2015.03.027
- 11.
- 12.
Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381-388.
Not in our library10.1080/15476286.2015.1020271
- 13.
- 14.
- 15.
Guo LL, Song CH, Wang P, Dai LP, Zhang JY, Wang KJ. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol. 2015;21(41):11680-11687.
Not in our library10.3748/wjg.v21.i41.11680
- 16.
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981-984.
Not in our library10.1038/cr.2015.82
- 17.
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384-388.
Not in our library10.1038/nature11993
- 18.
Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochim Biophys Acta. 2016;1859(1):163-168.
Not in our library10.1016/j.bbagrm.2015.07.007
- 19.
Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73(18):5609-5612.
Not in our library10.1158/0008-5472.can-13-1568
- 20.
Su H, Jin X, Zhang X, Xue S, Deng X, Shen L, Fang Y, Xie C. Identification of microRNAs involved in the radioresistance of esophageal cancer cells. Cell Biol Int. 2014;38(3):318-325.
Not in our library10.1002/cbin.10202
- 21.
Su H, Jin X, Zhang X, Zhao L, Lin B, Li L, Fei Z, Shen L, Fang Y. Pan H10, Xie C. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R. J Transl Med. 2015;13:104.
Not in our library10.1186/s12967-015-0464-6
- 22.
Su H, Jin X, Shen L, Fang Y, Fei Z, Zhang X, Xie C, Chen X. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells. Tumour Biol. 2015.
Not in our library10.1007/s13277-015-4393-z
- 23.
Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, Piechotta M, Levanon EY, Landthaler M, Dieterich C, Rajewsky N. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10(2):170-177.
Not in our library10.1016/j.celrep.2014.12.019
- 24.
Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW, Zeillinger R, Pils D. Correlation of circular RNA abundance with proliferation—exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057.
Not in our library10.1038/srep08057
- 25.
Qu S, Song W, Yang X, Wang J, Zhang R, Zhang Z, Zhang H, Li H. Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma. Genom Data. 2015;5:385-387.
Not in our library10.1016/j.gdata.2015.07.017
- 26.
Li P, Chen S, Chen H, Mo X, Li T, Shao Y, Xiao B, Guo J. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta. 2015;444:132-136.
Not in our library10.1016/j.cca.2015.02.018
- 27.
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z, Yang J, Fan J, Liu L, Qin W. Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomark. 2016;16(1):161-169.
Not in our library10.3233/cbm-150552
- 28.
- 29.
Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell. 2014;54(5):766-776.
Not in our library10.1016/j.molcel.2014.03.045
- 30.
Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2015.
Not in our library10.1080/15476286.2015.1122162
- 31.
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang S, Xu D, Lin HK, Gong Z. Circular RNAs in cancer: novel insights into origins, properties, functions and implications. Am J Cancer Res. 2015;5(2):472-480.
Not in our library
- 32.
Gusev Y. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods. 2008;44(1):61-72.
Not in our library10.1016/j.ymeth.2007.10.005
- 33.
Toulany M, Rodemann HP. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. Semin Cancer Biol. 2015;35:180-190.
Not in our library10.1016/j.semcancer.2015.07.003
- 34.
Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Wnt activation is implicated in glioblastoma radioresistance. Lab Invest. 2012;92(3):466-473.
Not in our library10.1038/labinvest.2011.161
- 35.
Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA, Telegeev GD, Stakhovsky EA, Walker JR, Simin K, Lyle S, Fuessel S, Erdmann K, Wirth MP, Krause M, Baumann M, Dubrovska A. Aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells. Cancer Res. 2015;75(7):1482-1494.
Not in our library10.1158/0008-5472.can-14-1924
Cited by papers we hold 15
- The functional roles of the circRNA/Wnt axis in cancer · 2022No notice
- Roles of circRNAs in the tumour microenvironment · 2020No notice
- CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a · 2020No notice
- Role of non-coding RNAs and RNA modifiers in cancer therapy resistance · 2020No notice
- Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance · 2020No notice
- circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma · 2020No notice
- CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway · 2019No notice
- Circular RNAs: a new frontier for cancer diagnosis and therapy · 2018No notice
- Function and clinical significance of circRNAs in solid tumors · 2018No notice
- Global circular RNA expression profile of human gastric cancer and its clinical significance · 2017No notice
- Circular RNAs in cancer: opportunities and challenges in the field · 2017No notice
- Circular RNAs in human cancer · 2017No notice
- Circular RNAs: emerging cancer biomarkers and targets · 2017No notice
- Characterization of hsa_circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis · 2017No notice
- An emerging function of circRNA-miRNAs-mRNA axis in human diseases · 2017No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.